Thorne, MD, PhD, discusses evidence from the ADJUST trial, including relapse risk, retreatment success, and how clinicians ...
The owner of a pregnant “miracle” mare who survived life-threatening sepsis that made her temporarily blind has praised the ...
Recently, VivaVision Biotech (VivaVision), a late clinical-stage, privately-held biotech company focused on developing innovative ophthalmic drugs, announced that it has received the written meeting ...
Pfizer Inc. today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, ...
A PONY breeder has praised a North Yorkshire equine hospital for saving the life of their seriously ill miniature Shetland Pony and her unborn foal.
Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 monthsNotable ...
Patients who experience adverse ocular effects with bisphosphonates have a notably higher risk for osteonecrosis than those who do not experience such events, a large cohort study shows.
A North Yorkshire pony breeder has credited Rainbow Equine Hospital in Malton for saving the life of Parlington Flair, a ...
The Scarborough News on MSN
'Extremely special' mare and unborn foal survive sepsis thanks to Ryedale equine hospital
A pony breeder has praised a Ryedale equine hospital for saving the life of their seriously ill Miniature Shetland Pony and ...
A North Yorkshire pony breeder has credited Rainbow Equine Hospital in Malton for saving the life of Parlington Flair, a seriously ...
Investing.com – Leerink Partners hat das "Outperform"-Rating und das Kursziel von 32,00 US-Dollar für die Aktie von Roivant Sciences (NASDAQ:ROIV) bestätigt und begründet dies mit der Erwartung positi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback